What is the share price of Choksi Laboratories Ltd (CHOKSILA) today?
The share price of CHOKSILA as on 8th July 2025 is ₹179.30. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.What is the return on Choksi Laboratories Ltd (CHOKSILA) share?
The past returns of Choksi Laboratories Ltd (CHOKSILA) share are- Past 1 week: 1.03%
- Past 1 month: 29.41%
- Past 3 months: 61.64%
- Past 6 months: 57.38%
- Past 1 year: 225.12%
- Past 3 years: 466.36%
- Past 5 years: 1726.50%
What are the peers or stocks similar to Choksi Laboratories Ltd (CHOKSILA)?
The peers or stocks similar to Choksi Laboratories Ltd (CHOKSILA) include:What is the market cap of Choksi Laboratories Ltd (CHOKSILA) share?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Choksi Laboratories Ltd (CHOKSILA) is ₹127.22 Cr as of 8th July 2025.What is the 52 week high and low of Choksi Laboratories Ltd (CHOKSILA) share?
The 52-week high of Choksi Laboratories Ltd (CHOKSILA) is ₹197.95 and the 52-week low is ₹55.40.What is the PE and PB ratio of Choksi Laboratories Ltd (CHOKSILA) stock?
The P/E (price-to-earnings) ratio of Choksi Laboratories Ltd (CHOKSILA) is 83.70. The P/B (price-to-book) ratio is 5.73.Which sector does Choksi Laboratories Ltd (CHOKSILA) belong to?
Choksi Laboratories Ltd (CHOKSILA) belongs to the Health Care sector & Labs & Life Sciences Services sub-sector.How to buy Choksi Laboratories Ltd (CHOKSILA) shares?
You can directly buy Choksi Laboratories Ltd (CHOKSILA) shares on Tickertape. Simply sign up, connect your demat account and place your order.
Choksi Laboratories Ltd
CHOKSILA Share Price
179.301.83% (-3.35)
High
—
—
Low
—
—
Returns
—
—
1D
1W
1M
1Y
5Y
Max
SIP
1D
1W
1M
1Y
5Y
Max
SIP
CHOKSILA Stock Scorecard
Performance
HighThe creamy layer - amongst the top performing stocks
Valuation
HighSeems to be overvalued vs the market average
Growth
AvgFinancials growth has been moderate for a few years
Profitability
HighShowing good signs of profitability & efficiency
Entry point
AvgThe stock is not in the overbought zone
Red flags
AvgThe stock has a moderate number of red flags
How to use scorecard? Learn more
CHOKSILA Performance & Key Metrics
CHOKSILA Performance & Key Metrics
| No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
|---|---|---|
| 83.15 | 5.73 | — |
| Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
|---|---|---|
| 36.97 | 6.46 | 0.64% |
CHOKSILA Analyst Ratings & Forecast
—
Analyst Ratings data is currently unavailable for this stockPrice Upside
Earnings Growth
Rev. Growth
CHOKSILA Company Profile
Choksi Laboratories Ltd provides contract testing and analytical services for pharmaceuticals, food, and environmental monitoring, ensuring compliance and quality assurance.
DIVISLAB
PE Ratio
83.46
83.46
1Y Return
54.31%
54.31%
Buy Reco %
52.17
52.17
SYNGENE
PE Ratio
51.44
51.44
1Y Return
13.18%
13.18%
Buy Reco %
71.43
71.43
AARTIPHARM
PE Ratio
29.92
29.92
1Y Return
43.11%
43.11%
Buy Reco %
0.00
0.00
PE Ratio
1,287.17
1,287.17
1Y Return
54.80%
54.80%
Buy Reco %
0.00
0.00
VIMTALABS
PE Ratio
30.49
30.49
1Y Return
79.91%
79.91%
Buy Reco %
0.00
0.00
CHOKSILA Forecast
CHOKSILA Forecasts
Forecast data is currently unavailable
Forecast data is currently unavailable
Price
Price Upside
Revenue
Revenue Growth
Earnings
Earnings Per Share
CHOKSILA
CHOKSILA
Income
Balance Sheet
Cash Flow
Annual Normal View
CHOKSILA Income Statement
CHOKSILA Income Statement
Annual Normal View
| Financial Year | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | TTM | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 29.62 | 30.77 | 34.00 | 28.49 | 26.18 | 30.16 | 37.48 | 36.86 | 41.85 | 41.84 | ||||||||||
Raw Materials | 2.97 | 3.47 | 3.95 | 3.24 | 2.57 | 1.98 | 2.21 | 2.56 | 30.55 | 30.54 | ||||||||||
| Power & Fuel Cost | 0.74 | 0.73 | 0.77 | 0.78 | 0.66 | 0.70 | 0.83 | 0.84 | ||||||||||||
| Employee Cost | 8.76 | 10.51 | 11.47 | 11.70 | 10.78 | 11.04 | 12.00 | 13.03 | ||||||||||||
| Selling & Administrative Expenses | 5.45 | 6.48 | 7.24 | 5.96 | 4.65 | 4.69 | 6.06 | 6.43 | ||||||||||||
| Operating & Other expenses | 6.06 | 2.89 | 3.06 | 6.06 | 2.91 | 2.72 | 3.64 | 3.56 | ||||||||||||
EBITDA | 5.64 | 6.69 | 7.51 | 0.75 | 4.61 | 9.03 | 12.74 | 10.44 | 11.30 | 11.30 | ||||||||||
| Depreciation/Amortization | 2.86 | 3.16 | 3.68 | 4.56 | 4.60 | 5.43 | 5.50 | 5.71 | 6.50 | 6.49 | ||||||||||
| PBIT | 2.78 | 3.53 | 3.83 | -3.81 | 0.01 | 3.60 | 7.24 | 4.73 | 4.80 | 4.81 | ||||||||||
| Interest & Other Items | 1.47 | 1.59 | 1.54 | 1.89 | 2.82 | 3.23 | 3.52 | 3.06 | 2.65 | 2.65 | ||||||||||
| PBT | 1.31 | 1.94 | 2.29 | -5.70 | -2.81 | 0.37 | 3.72 | 1.67 | 2.15 | 2.16 | ||||||||||
| Taxes & Other Items | 0.42 | 0.58 | 0.69 | -1.83 | -0.20 | 0.16 | 0.51 | 0.55 | 0.63 | 0.63 | ||||||||||
| Net Income | 0.89 | 1.36 | 1.60 | -3.87 | -2.61 | 0.21 | 3.21 | 1.12 | 1.52 | 1.53 | ||||||||||
| EPS | 1.28 | 1.95 | 2.30 | -5.56 | -3.75 | 0.30 | 4.61 | 1.61 | 2.19 | 2.20 | ||||||||||
| DPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||||||
| Payout ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
CHOKSILA Company Updates
CHOKSILA Stock Peers
CHOKSILA Past Performance & Peer Comparison
CHOKSILA Past Performance & Peer Comparison
Comparing 3 stocks from
Health CareLabs & Life Sciences Services
Compare valuation-basic on Screener
Health CareLabs & Life Sciences Services
Valuation
Technical
Forecast
Compare valuation-basic on Screener| Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
|---|---|---|---|
| Choksi Laboratories Ltd | 83.70 | 5.73 | — |
| Divi's Laboratories Ltd | 83.46 | 13.47 | 0.44% |
| Syngene International Ltd | 51.44 | 5.40 | 0.20% |
| Aarti Pharmalabs Ltd | 29.92 | 4.64 | 0.56% |
CHOKSILA Stock Price Comparison
Compare CHOKSILA with any stock or ETFCompare CHOKSILA with any stock or ETF
CHOKSILA
CHOKSILA Holdings
CHOKSILA Shareholdings
CHOKSILA Promoter Holdings Trend
CHOKSILA Promoter Holdings Trend
Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook
In last 6 months, promoter holding in the company has almost stayed constant
Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better
Pledged promoter holdings is insignificant
CHOKSILA Institutional Holdings Trend
CHOKSILA Institutional Holdings Trend
Decreased Total Retail Holding
Increasing retail holding can be considered bad as it can reflect that institutions and promoters are selling their stake which is being absorbed by retail investors.
In last 3 months, retail holding in the company has decreased by 4.52%
Increased Foreign Institutional Holding
Foreign Institutional Holding is quantum of stock held by foreign large-quantities-trading entities. Increasing value indicates growing support and comfort for the stock
In last 3 months, foreign institutional holding of the company has increased by 1.94%
CHOKSILA Shareholding Pattern
CHOKSILA Shareholding Pattern
CHOKSILA Shareholding History
CHOKSILA Shareholding History
Foreign Institutions
smallcases containing CHOKSILA stock
smallcases containing CHOKSILA stock
Looks like this stock is not in any smallcase yet.
CHOKSILA Events
CHOKSILA Events
CHOKSILA Dividend Trend
No Dividends
Dividends are the portion of earnings that a company distributes to all its shareholders every year
CHOKSILA has not given any dividends in last 5 years
Dividends
Corp. Actions
Announcements
Legal Orders
Dividends
CHOKSILA Dividend Trend
No Dividends
Dividends are the portion of earnings that a company distributes to all its shareholders every year
CHOKSILA has not given any dividends in last 5 years
CHOKSILA Dividends
CHOKSILA Dividends
Hmm, looks like data is unavailable here. Please come back after some timeCHOKSILA Stock News & Opinions
CHOKSILA Stock News & Opinions
Articles & Videos
Earnings
Choksi Laboratories standalone net profit rises 35.29% in the March 2025 quarter
Net profit of Choksi Laboratories rose 35.29% to Rs 0.92 crore in the quarter ended March 2025 as against Rs 0.68 crore during the previous quarter ended March 2024. Sales rose 2.52% to Rs 11.40 crore in the quarter ended March 2025 as against Rs 11.12 crore during the previous quarter ended March 2024. For the full year,net profit rose 36.94% to Rs 1.52 crore in the year ended March 2025 as against Rs 1.11 crore during the previous year ended March 2024. Sales rose 13.84% to Rs 41.78 crore in the year ended March 2025 as against Rs 36.70 crore during the previous year ended March 2024. ParticularsQuarter EndedYear EndedMar. 2025Mar. 2024% Var.Mar. 2025Mar. 2024% Var. Sales11.4011.12 3 41.7836.70 14 OPM %30.7031.29 -26.8827.85 - PBDT2.962.77 7 8.657.37 17 PBT1.261.28 -2 2.151.66 30 NP0.920.68 35 1.521.11 37 Powered by Capital Market - Live
4 weeks agoCapital Market - Live
Corporate
Choksi Laboratories to discuss results
Choksi Laboratories will hold a meeting of the Board of Directors of the Company on 7 June 2025.Powered by Capital Market - Live
1 month agoCapital Market - Live
Corporate
Choksi Laboratories to discuss results
Choksi Laboratories will hold a meeting of the Board of Directors of the Company on 29 May 2025.Powered by Capital Market - Live
1 month agoCapital Market - Live
Earnings
Choksi Laboratories standalone net profit rises 83.33% in the December 2024 quarter
Net profit of Choksi Laboratories rose 83.33% to Rs 0.11 crore in the quarter ended December 2024 as against Rs 0.06 crore during the previous quarter ended December 2023. Sales rose 18.09% to Rs 10.38 crore in the quarter ended December 2024 as against Rs 8.79 crore during the previous quarter ended December 2023. ParticularsQuarter EndedDec. 2024Dec. 2023% Var. Sales10.388.79 18 OPM %24.5725.48 - PBDT1.871.57 19 PBT0.190.14 36 NP0.110.06 83 Powered by Capital Market - Live
4 months agoCapital Market - Live
Corporate
Choksi Laboratories to announce Quarterly Result
Choksi Laboratories will hold a meeting of the Board of Directors of the Company on 14 February 2025.Powered by Capital Market - Live
4 months agoCapital Market - Live
Earnings
Choksi Laboratories standalone net profit rises 700.00% in the September 2024 quarter
Net profit of Choksi Laboratories rose 700.00% to Rs 0.08 crore in the quarter ended September 2024 as against Rs 0.01 crore during the previous quarter ended September 2023. Sales rose 16.48% to Rs 9.26 crore in the quarter ended September 2024 as against Rs 7.95 crore during the previous quarter ended September 2023. ParticularsQuarter EndedSep. 2024Sep. 2023% Var. Sales9.267.95 16 OPM %25.4926.54 - PBDT1.711.42 20 PBT0.100.01 900 NP0.080.01 700 Powered by Capital Market - Live
7 months agoCapital Market - Live
Corporate
Choksi Laboratories to convene board meeting
Choksi Laboratories will hold a meeting of the Board of Directors of the Company on 14 November 2024Powered by Capital Market - Live
8 months agoCapital Market - Live
Corporate
Choksi Laboratories to conduct AGM
Choksi Laboratories announced that the Annual General Meeting (AGM) of the company will be held on 21 September 2024.Powered by Capital Market - Live
10 months agoCapital Market - Live
Corporate
Choksi Laboratories to hold AGM
Choksi Laboratories announced that the Annual General Meeting (AGM) of the company will be held on 21 September 2024.Powered by Capital Market - Live
10 months agoCapital Market - Live
Corporate
Choksi Laboratories to table results
Choksi Laboratories will hold a meeting of the Board of Directors of the Company on 13 August 2024.Powered by Capital Market - Live
11 months agoCapital Market - Live
Over the last 5 years, revenue has grown at a yearly rate of 7.99%, vs industry avg of 7.5%
Over the last 5 years, market share decreased from 0.23% to 0.21%